TP53 and neoplasm: For these nine signaling pathways, including cell cycle, Hippo, MYC, Notch, NRF2, TP53, PI3K, RTK‐RAS, and WNT, the genomic alterations promoting oncogenic activities while inactivating tumor suppressor functions were much more frequently observed in TS‐CB and TS‐CC than in TS‐CA.